Auna S.A. (AUNA), a Latin American healthcare platform operating hospitals, clinics, and health plans across Mexico, Peru, and Colombia, saw its stock plunge in Thursday's session after the company slashed its 2026 Adjusted EBITDA outlook. The shares fell approximately 14.6%, dropping to about $4.62 from the previous session's closing price of $5.41. Markets pointed to the guidance downgrade — driven by unexpected cost pressure tied to a Colombian payor contract — as the immediate reason for the sell-off.
The decisive driver of the decline was Auna's announcement that it now expects consolidated Adjusted EBITDA to be broadly stable year over year for 2026, a sharp downgrade from its earlier guidance of 10% to 14% growth on an FX-neutral basis. The revision follows an unexpectedly high incidence of advanced-stage cancer cases within a covered population under a specific payor contract in Colombia, which has created additional temporary cost pressure for the company.
The move represents a step down from signals management had already given during its second-quarter earnings call, when it indicated full-year Adjusted EBITDA growth was expected to land at the lower end of guidance excluding one-time effects. The further cut caught investors off guard, triggering a broad repricing of the stock.
Despite the profit warning, Auna maintained its full-year 2026 revenue guidance of approximately 12% FX-neutral growth. The company attributed that confidence to a continued strong recovery in its Mexico operations during the second half of the year, with recently disclosed operating KPIs reflecting favorable volume and specialty-service trends in the third quarter.
Capital expenditures also remain within the previously communicated range of roughly 4.0% of consolidated revenue, and the company said free cash flow and leverage continue to evolve favorably. Those stabilizing factors, however, were not enough to offset investor concern over the profitability reset in Colombia.
The stock's decline came on a day when Auna was also hosting its 2026 Investor Day, at which management discussed its long-term strategy across Mexico, Peru, and Colombia. The guidance revision overshadowed the event, and selling pressure was evident from the premarket session onward, with the shares gapping down sharply before settling near the lows.
The move reflected company-specific fundamentals rather than broad sector weakness, as the negative catalyst — a contract-driven cost surprise — was idiosyncratic to Auna's Colombian operations. Management noted it is still completing its review of the payor contract's implications for full-year Adjusted EBITDA, leaving some uncertainty about whether further adjustments could follow.
Investors will now focus on Auna's third-quarter 2026 earnings call, where management has said it will provide additional detail on the Colombia payor contract and its effect on full-year Adjusted EBITDA. The company has indicated that its revenue trajectory remains intact, but the key question is whether the cost pressures prove temporary, as management described, or persist into future quarters.
Beyond the upcoming earnings report, traders will monitor the pace of Mexico's operational recovery, the stability of Auna's free cash flow and leverage metrics, and any further disclosures on the Colombia contract. The reset in guidance introduces meaningful uncertainty around near-term profitability, even as the top-line outlook remains supportive.
For traders seeking a data-driven edge, Tickeron's Trending AI Robots page highlights AI-powered trading bots that are performing well under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers are featured in this curated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, giving users a range of approaches to explore. Visit the page to see which strategies are currently leading the market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AUNA moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend. In 19 of 23 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on AUNA as a result. In 37 of 54 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for AUNA just turned positive on October 08, 2026. Looking at past instances where AUNA's MACD turned positive, the stock continued to rise in 16 of 21 cases over the following month. The odds of a continued upward trend are 76%.
The 10-day moving average for AUNA crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +2.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where AUNA advanced for three days, in 72 of 116 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The 10-day RSI Indicator for AUNA moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 11 similar instances where the indicator moved out of overbought territory. In 7 of the 11 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AUNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
AUNA broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AUNA entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. AUNA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.215) is normal, around the industry mean (204.137). P/E Ratio (24.591) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.095) among similar stocks. P/S Ratio (0.289) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AUNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry HospitalNursingManagement